Neoadjuvant FOLFOX Chemotherapy for Patients With Locally Advanced Colon Cancer
NCT03426904
·
clinicaltrials.gov ↗
PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
708
Enrollment
OTHER
Sponsor class
Conditions
Colon Cancer
Interventions
DRUG:
Neoadjuvant FOLFOX
DRUG:
Conventional adjuvant FOLFOX
Sponsor
Kyungpook National University Hospital